siRNA therapy lowers triglycerides in individuals with uncommon health condition

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride amounts through 80% as well as decreased the risk of pancreatitis in people with constant chylomicronemia, along with or even without a hereditary prognosis.

Articles You Can Be Interested In

• Biotech
• Spirituality
• Productivity
• Blockchain
• Mental Health
• Volunteering
• Holidays
• Education
• Psychology
• Customer Service
• Advertising
• US Politics
• Motivation
• Investment
• Video Production
• Weddings
• Customer Service
• Mental Health
• Networking
• Tax Planning